| Literature DB >> 29523227 |
Akiomi Yoshihisa1, Yusuke Kimishima2, Takatoyo Kiko2, Yu Sato2, Shunsuke Watanabe2, Yuki Kanno2, Satoshi Abe2, Makiko Miyata2, Takamasa Sato2, Satoshi Suzuki2, Masayoshi Oikawa2, Atsushi Kobayashi2, Takayoshi Yamaki2, Hiroyuki Kunii2, Kazuhiko Nakazato2, Takafumi Ishida2, Yasuchika Takeishi2.
Abstract
Titin is associated with myocardial stiffness and hypertrophy, and mutations in its gene have been identified in cardiac myopathies such as dilated cardiomyopathy (DC). It has recently been reported that in damaged muscle, the N-terminal fragment of titin (Titin-N) is cleaved by calpain-3, and urinary Titin-N (U-TN) could be a marker of sarcomere damage. We aimed to investigate the impact of U-TN on prognosis of DC. We measured urinary levels of Titin-N/creatinine ratio (U-TN/Cr; pmol/mg/dl) in 102 patients with DC, and followed up all the patients (mean 1,167 days). The patients were divided into 3 groups based on the U-TN/Cr: first (U-TN/Cr <3.35, n = 34), second (3.35 ≤ U-TN/Cr <7.26, n = 34), and third (7.26 ≤ U-TN/Cr, n = 34) tertiles. In the Kaplan-Meier analysis, cardiac and all-cause mortality progressively increased from the first to the second and third groups (p <0.05, respectively). In the Cox proportional hazard analyses, U-TN/Cr was a predictor of cardiac and all-cause mortality in patients with DC (p <0.05, respectively). U-TN, a possible marker of sarcomere damage, can identify high-risk patients with DC.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29523227 DOI: 10.1016/j.amjcard.2018.01.046
Source DB: PubMed Journal: Am J Cardiol ISSN: 0002-9149 Impact factor: 2.778